MarketInOut Stock Screener Log In | Sign Up

Aprilbio Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026
Aprilbio Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization288,927 mln
Float13.80 mln

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

4.73
Highly suspicious

Relative Strength

33 / 100
Underperforming

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-1,190%
Severely loss-making

ROE

-9.16
Negative

Business Description

AprilBio is a South Korean biotechnology company founded in 2013 and based in Chuncheon-si. The company focuses on developing advanced antibody-based medicines, including long-acting biologics and drug-conjugated antibodies designed to work more effectively and last longer in the body. Its research targets a range of serious health conditions, including rare diseases, cancer, autoimmune disorders, inflammatory diseases, and male infertility.

Key Fundamentals

EPS-394
ROE-9.16
RPS31.43
ROIC-119
ROA-8.84
EBITDA, mln-7,733
EV / EBITDA-61.57
EV / EBIT-56.77
Revenue, mln725
EV / Revenue656

Quote Details

Last 11,810
Change -590 (-4.76%)
Open 12,210
Volume 252,883
Turnover 2,986,548,224
Average Volume 267,551

Financial Ratios

Pre-Tax Profit Margin-1,190
Current Ratio67.70
Price / Book4.88
Price / Tangible Book4.94
Debt / Equity0.01
Price / Sales650

Financial Strength

Altman Z-Score228
Piotroski F-Score 2 / 9
Beneish M-Score4.73

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.37% 16 / 100   
1 Month -36.81% 2 / 100   
2 Months -49.74% 1 / 100   
6 Months -79.85% 0 / 100   
1 Year -63.15% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog